Page last updated: 2024-10-24

candesartan and Angiomyolipoma

candesartan has been researched along with Angiomyolipoma in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Angiomyolipoma: A benign tumor containing vascular, adipose, and muscle elements. It occurs most often in the kidney with smooth muscle elements (angiolipoleiomyoma) in association with tuberous sclerosis. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katayama, A1
Otsuka, F1
Tanabe, K1
Tsukamoto, N1
Yamanaka, R1
Matsumoto, Y1
Nasu, Y1
Makino, H1

Other Studies

1 other study available for candesartan and Angiomyolipoma

ArticleYear
Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:5

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Angiomyolipoma; Antihyperten

2011